This company is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Ceapro Beheer
Beheer criteriumcontroles 3/4
Ceapro's CEO is Gilles Gagnon, appointed in Jan 2008, has a tenure of 16.42 years. total yearly compensation is CA$560.00K, comprised of 85.7% salary and 14.3% bonuses, including company stock and options. directly owns 1.9% of the company’s shares, worth CA$335.03K. The average tenure of the management team and the board of directors is 9.1 years and 9.2 years respectively.
Belangrijke informatie
Gilles Gagnon
Algemeen directeur
CA$560.0k
Totale compensatie
Percentage CEO-salaris | 85.7% |
Dienstverband CEO | 16.4yrs |
Eigendom CEO | 1.9% |
Management gemiddelde ambtstermijn | 9.1yrs |
Gemiddelde ambtstermijn bestuur | 9.2yrs |
Recente managementupdates
Recent updates
The Returns At Ceapro (CVE:CZO) Aren't Growing
Aug 09Returns At Ceapro (CVE:CZO) Are On The Way Up
Oct 15Ceapro's (CVE:CZO) Returns Have Hit A Wall
Jun 17Ceapro (CVE:CZO) Will Want To Turn Around Its Return Trends
Nov 19Be Wary Of Ceapro (CVE:CZO) And Its Returns On Capital
Jul 20Ceapro's (CVE:CZO) Robust Earnings Are Supported By Other Strong Factors
May 27Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)
Apr 29Will Ceapro (CVE:CZO) Multiply In Value Going Forward?
Mar 01Is It Too Late To Consider Buying Ceapro Inc. (CVE:CZO)?
Feb 01Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)
Jan 06Ceapro Inc. (CVE:CZO) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 28Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -CA$5m |
Sep 30 2023 | n/a | n/a | -CA$3m |
Jun 30 2023 | n/a | n/a | -CA$759k |
Mar 31 2023 | n/a | n/a | CA$2m |
Dec 31 2022 | CA$560k | CA$480k | CA$4m |
Sep 30 2022 | n/a | n/a | CA$6m |
Jun 30 2022 | n/a | n/a | CA$6m |
Mar 31 2022 | n/a | n/a | CA$5m |
Dec 31 2021 | CA$560k | CA$480k | CA$3m |
Sep 30 2021 | n/a | n/a | CA$2m |
Jun 30 2021 | n/a | n/a | CA$844k |
Mar 31 2021 | n/a | n/a | CA$1m |
Dec 31 2020 | CA$507k | CA$480k | CA$2m |
Sep 30 2020 | n/a | n/a | CA$3m |
Jun 30 2020 | n/a | n/a | CA$2m |
Mar 31 2020 | n/a | n/a | CA$630k |
Dec 31 2019 | CA$518k | CA$480k | -CA$1m |
Sep 30 2019 | n/a | n/a | -CA$855k |
Jun 30 2019 | n/a | n/a | -CA$1m |
Mar 31 2019 | n/a | n/a | -CA$657k |
Dec 31 2018 | CA$555k | CA$480k | -CA$316k |
Sep 30 2018 | n/a | n/a | -CA$2m |
Jun 30 2018 | n/a | n/a | -CA$2m |
Mar 31 2018 | n/a | n/a | -CA$1m |
Dec 31 2017 | CA$1m | CA$480k | -CA$958k |
Compensatie versus markt: Gilles's total compensation ($USD410.93K) is above average for companies of similar size in the Canadian market ($USD176.99K).
Compensatie versus inkomsten: Gilles's compensation has been consistent with company performance over the past year.
CEO
Gilles Gagnon (70 yo)
16.4yrs
Tenure
CA$560,000
Compensatie
Mr. Gilles R. Gagnon, M.Sc. MBA, ICD D, serves as Independent Director of Aeterna Zentaris Inc. since January 1, 2020. He serves as the President of Spectrum Pharma Canada Inc. (Spectrum Canada).Mr. Gagno...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President & Director | 16.4yrs | CA$560.00k | 1.9% CA$ 335.0k | |
CFO & Corporate Secretary | 9.1yrs | CA$232.99k | 0.042% CA$ 7.3k | |
Senior Director of Research & Technology | no data | geen gegevens | geen gegevens | |
Senior Vice President of Technical Operations | 1.1yrs | geen gegevens | geen gegevens |
9.1yrs
Gemiddelde duur
Ervaren management: CZO's management team is seasoned and experienced (9.1 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President & Director | 16.8yrs | CA$560.00k | 1.9% CA$ 335.0k | |
Independent Director | 2.2yrs | CA$92.38k | geen gegevens | |
Independent Director | 9.6yrs | CA$59.57k | 0.13% CA$ 22.9k | |
Independent Chairman | 2.1yrs | CA$96.06k | geen gegevens | |
Independent Director | 9.2yrs | CA$57.79k | 0.10% CA$ 17.6k |
9.2yrs
Gemiddelde duur
Ervaren bestuur: CZO's board of directors are considered experienced (9.2 years average tenure).